Edition:
United States

Santhera Pharmaceuticals Holding AG (SANN.S)

SANN.S on Swiss Exchange

34.65CHF
15 Dec 2017
Change (% chg)

CHF3.65 (+11.77%)
Prev Close
CHF31.00
Open
CHF32.85
Day's High
CHF34.75
Day's Low
CHF31.60
Volume
193,912
Avg. Vol
67,105
52-wk High
CHF82.00
52-wk Low
CHF25.10

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 2 23.00 24.00 22.00 52.20
Year Ending Dec-18 2 45.40 46.00 44.80 102.43
Earnings (per share)
Year Ending Dec-17 2 -5.82 -5.72 -5.91 2.89
Year Ending Dec-18 2 -2.11 -1.16 -3.06 6.03
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. 80.56 40.75 45.35
P/E Low - Last 5 Yrs. 80.56 23.60 24.23
Beta 0.83 0.92 0.91
Price to Sales (TTM) 9.60 3.92 5.95
Price to Book (MRQ) 3.94 4.85 5.68
Price to Tangible Book (MRQ) 7.22 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions -- 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg 0.00 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 50.61 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago 125.11 5.15 5.62
Sales - 5 Yr. Growth Rate 42.27 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.13 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago -778.32 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate 33.33 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.73 2.49 2.55
Current Ratio (MRQ) 8.57 3.50 3.56
LT Debt to Equity (MRQ) 94.97 11.01 13.38
Total Debt to Equity (MRQ) 94.97 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 82.69 55.26 54.91
Gross Margin - 5 Yr. Avg. 80.71 52.35 52.46
EBITD Margin (TTM) -149.78 -- --
EBITD - 5 Yr. Avg -254.40 18.50 15.63
Operating Margin (TTM) -164.39 14.76 6.56
Operating Margin - 5 Yr. Avg. -247.87 14.33 11.00
Pre-Tax Margin (TTM) -170.74 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -244.33 14.64 11.41
Net Profit Margin (TTM) -177.04 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -242.25 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 302,427 945,342,213 851,801,741
Net Income/Employee (TTM) -535,413 110,573,246 99,542,701
Receivable Turnover (TTM) 5.17 5.90 6.13
Inventory Turnover (TTM) 0.51 2.73 3.56
Asset Turnover (TTM) 0.19 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.17 11.86 11.31
Return on Assets - 5 Yr. Avg. -31.14 12.86 12.28
Return on Investment (TTM) -37.59 15.06 14.43
Return on Investment - 5 Yr. Avg. -34.37 16.81 16.07
Return on Equity (TTM) -55.62 16.55 16.01
Return on Equity - 5 Yr. Avg. -37.23 17.82 17.27
  1 Year 3 Year 5 Year
Sales % 340.48 143.46 42.27
EPS (TTM) % -607.02 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Santhera Pharmaceuticals Holding AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.28 5.85 99 49
13 Week -10.58 -14.07 86 16
26 Week -39.58 -42.36 34 31
52 Week -24.01 -33.56 69 25
YTD -34.62 -42.80 48 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.75%
# of Holders: 43
Total Shares Held: 1,932,642
3 Mo. Net Change: 597,396
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 9
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.